Mechanism of Action: Iron Chelating Activity
✉ Email this page to a colleague
Drugs with Mechanism of Action: Iron Chelating Activity
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annora Pharma | DEFERASIROX | deferasirox | TABLET;ORAL | 214341-003 | May 14, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Alembic | DEFERASIROX | deferasirox | TABLET, FOR SUSPENSION;ORAL | 210060-001 | Nov 20, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Aurobindo Pharma Ltd | DEFERASIROX | deferasirox | TABLET;ORAL | 214474-002 | Oct 16, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ichnos | DEFERASIROX | deferasirox | TABLET, FOR SUSPENSION;ORAL | 209433-001 | Jan 6, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Msn | DEFERASIROX | deferasirox | TABLET;ORAL | 210945-003 | Jun 16, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Alkem Labs Ltd | DEFERASIROX | deferasirox | TABLET, FOR SUSPENSION;ORAL | 210519-002 | Nov 20, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Cipla | DEFERASIROX | deferasirox | GRANULE;ORAL | 215026-003 | Feb 23, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |